Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,368 public trials 407 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

NCT02731729

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)

NCT02434107

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Humboldt-Universität Berlin Charité Berlin, Germany
  • Krankenhaus Neukölln Berlin, Germany
  • Universtitäts-Hautklinik Bochum Bochum, Germany
  • Zentralkrankenhaus Bremen, Germany
View all 41 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

NCT02857270

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 13 locations
View Trial Details

Related conditions